<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>glutamate Archives - Gateway Psychiatric</title>
	<atom:link href="https://www.gatewaypsychiatric.com/tag/glutamate/feed/" rel="self" type="application/rss+xml" />
	<link></link>
	<description>Excellent Psychiatric Care</description>
	<lastBuildDate>Fri, 02 Jul 2021 21:36:42 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.1</generator>

<image>
	<url>https://i0.wp.com/www.gatewaypsychiatric.com/wp-content/uploads/2013/06/favicon2.png?fit=32%2C32&#038;ssl=1</url>
	<title>glutamate Archives - Gateway Psychiatric</title>
	<link></link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">70562394</site>	<item>
		<title>Depression, Anhedonia, Glutamate, and Inflammation</title>
		<link>https://www.gatewaypsychiatric.com/depression-anhedonia-glutamate-inflammation/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Tue, 11 Oct 2016 19:40:09 +0000</pubDate>
				<category><![CDATA[Basic Science]]></category>
		<category><![CDATA[Major Depression]]></category>
		<category><![CDATA[Psychobiology]]></category>
		<category><![CDATA[c reactive protein]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[glutamate]]></category>
		<category><![CDATA[inflammation]]></category>
		<category><![CDATA[reward]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=11941</guid>

					<description><![CDATA[<p>That depression may be linked to alterations in glutamate circuits is suggested by the observation that ketamine (which is an NMDA glutamate receptor antagonist) may rapidly reverse depression in some patients. Depression has also been found to be associated in some people with various markers for inflammation (c reactive protein, tumor necrosis factor, interleukin 1 beta, and interleukin 6). As ... </p>
<div><a href="https://www.gatewaypsychiatric.com/depression-anhedonia-glutamate-inflammation/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/depression-anhedonia-glutamate-inflammation/">Depression, Anhedonia, Glutamate, and Inflammation</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">11941</post-id>	</item>
		<item>
		<title>Depression Therapeutics and Mechanisms</title>
		<link>https://www.gatewaypsychiatric.com/depression-therapeutics-mechanisms/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Sun, 25 Sep 2016 18:53:25 +0000</pubDate>
				<category><![CDATA[Major Depression]]></category>
		<category><![CDATA[Psychobiology]]></category>
		<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[amygdala]]></category>
		<category><![CDATA[bdnf]]></category>
		<category><![CDATA[biological psychiatry]]></category>
		<category><![CDATA[chronic stress]]></category>
		<category><![CDATA[creatine]]></category>
		<category><![CDATA[esketamine]]></category>
		<category><![CDATA[fibroblast growth factor]]></category>
		<category><![CDATA[gaba]]></category>
		<category><![CDATA[glutamate]]></category>
		<category><![CDATA[ketamine]]></category>
		<category><![CDATA[psychobiology]]></category>
		<category><![CDATA[ptsd]]></category>
		<category><![CDATA[tdcs]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=11920</guid>

					<description><![CDATA[<p>The September 15, 2016 edition of Biological Psychiatry is devoted to updates&#160;in the area of psychobiology that relate to depression and its treatment. In this blog post I will summarize some of those studies to give you a sense of what is going on in the field. Some of these studies may not be replicated in follow-up research, but some ... </p>
<div><a href="https://www.gatewaypsychiatric.com/depression-therapeutics-mechanisms/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/depression-therapeutics-mechanisms/">Depression Therapeutics and Mechanisms</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">11920</post-id>	</item>
		<item>
		<title>TMS Updates May 2015</title>
		<link>https://www.gatewaypsychiatric.com/tms-updates-may-2015/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Mon, 09 Nov 2015 19:50:17 +0000</pubDate>
				<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[bipolar depression]]></category>
		<category><![CDATA[ect]]></category>
		<category><![CDATA[geriatric depression]]></category>
		<category><![CDATA[glutamate]]></category>
		<category><![CDATA[tms]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=9350</guid>

					<description><![CDATA[<p>The editors of Bipolar News reported on some interesting presentations related to transcranial magnetic stimulation (TMS) at the Biological Psychiatry meetings this past May. TMS for geriatric depression &#8211; &#8220;Researcher Daniel Blumberger reported that he has found repeated transcranial magnetic stimulation (rTMS) to be effective for depression in late life. Blumberger noted thatit may be necessary to use higher intensity ... </p>
<div><a href="https://www.gatewaypsychiatric.com/tms-updates-may-2015/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/tms-updates-may-2015/">TMS Updates May 2015</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">9350</post-id>	</item>
		<item>
		<title>Beta Catenin and Depression</title>
		<link>https://www.gatewaypsychiatric.com/beta-catenin-depression/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Sun, 30 Nov 2014 17:26:03 +0000</pubDate>
				<category><![CDATA[Basic Science]]></category>
		<category><![CDATA[Major Depression]]></category>
		<category><![CDATA[Psychobiology]]></category>
		<category><![CDATA[anhedonia]]></category>
		<category><![CDATA[beta catenin]]></category>
		<category><![CDATA[bipolar or unipolar depression]]></category>
		<category><![CDATA[defeat]]></category>
		<category><![CDATA[glutamate]]></category>
		<category><![CDATA[ketamine]]></category>
		<category><![CDATA[nucleus accumbens]]></category>
		<category><![CDATA[psychobiology]]></category>
		<category><![CDATA[stress]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=8384</guid>

					<description><![CDATA[<p>Beta catenin is a molecule that may play a key role in preventing depression in those exposed to stress, at least if mice and humans share the same biology. Beta catenin is involved in a number of quite different functions in the cell. To give you an idea, it may be involved in the development of cancer (it is a ... </p>
<div><a href="https://www.gatewaypsychiatric.com/beta-catenin-depression/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/beta-catenin-depression/">Beta Catenin and Depression</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">8384</post-id>	</item>
		<item>
		<title>Bipolar Depression Neurobiology &#8211; 2014 ISBD Update</title>
		<link>https://www.gatewaypsychiatric.com/bipolar-depression-neurobiology-2014-isbd-update/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Tue, 11 Nov 2014 03:29:45 +0000</pubDate>
				<category><![CDATA[Bipolar Treatment]]></category>
		<category><![CDATA[Psychobiology]]></category>
		<category><![CDATA[bipolar]]></category>
		<category><![CDATA[bipolar or unipolar depression]]></category>
		<category><![CDATA[glutamate]]></category>
		<category><![CDATA[lamotrigine]]></category>
		<category><![CDATA[lithium]]></category>
		<category><![CDATA[magnetic resonance spectroscopy]]></category>
		<category><![CDATA[mechanism of action]]></category>
		<category><![CDATA[NAA]]></category>
		<category><![CDATA[neurobiology]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=8307</guid>

					<description><![CDATA[<p>Bipolar depression neurobiology is an area that urgently needs more research. The treatment of a depression that follows an energized (hypomanic or manic) state remains one of the most difficult areas in psychiatry. Mark Frye, Chair of the Department of Psychiatry at the Mayo Clinic, gave a presentation on this topic at the 2014 International Society of Biological Society conference that was ... </p>
<div><a href="https://www.gatewaypsychiatric.com/bipolar-depression-neurobiology-2014-isbd-update/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/bipolar-depression-neurobiology-2014-isbd-update/">Bipolar Depression Neurobiology &#8211; 2014 ISBD Update</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">8307</post-id>	</item>
		<item>
		<title>Ketamine for Depression &#8211; Mechanism of Action</title>
		<link>https://www.gatewaypsychiatric.com/ketamine-depression-mechanism-action/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Sat, 04 Oct 2014 16:15:42 +0000</pubDate>
				<category><![CDATA[Basic Science]]></category>
		<category><![CDATA[Major Depression]]></category>
		<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[glutamate]]></category>
		<category><![CDATA[ketamine]]></category>
		<category><![CDATA[NMDA]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[treatment resistant]]></category>
		<category><![CDATA[treatments of depression]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=8187</guid>

					<description><![CDATA[<p>Ketamine for Depression: How does it work? We ran across a useful review of the basic science literature in an interview of David Nichols on the Psych Congress Network. http://www.psychcongress.com/video/ketamine-quick-guide-receptors-19116 Although ketamine blocks the NMDA subtype of glutamate receptors (blocks an excitatory neurotransmitter) the net effect seems to be an increase in excitatory neurotransmission. This image from Nature may help ... </p>
<div><a href="https://www.gatewaypsychiatric.com/ketamine-depression-mechanism-action/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/ketamine-depression-mechanism-action/">Ketamine for Depression &#8211; Mechanism of Action</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">8187</post-id>	</item>
	</channel>
</rss>
